Posted 1 year, 11 months ago
We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised a $52M Series A from Andreessen Horowit…
Burlingame, CA
Posted 2 years ago
We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised a $52M Series A from Andreessen Horowit…
Remote, Onsite
Posted 2 years, 1 month ago
We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised a $52M Series A from Andreessen Horowit…
Remote, Burlingame, CA
Posted 2 years, 3 months ago
We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised a $52M Series A from Andreessen Horowit…
Remote, Onsite
Posted 2 years, 4 months ago
We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised a $52M Series A from Andreessen Horowit…
Burlingame, CA
Posted 2 years, 5 months ago
We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised a $52M Series A from Andreessen Horowit…
Remote, Onsite